Our Commitment

Every day, more than 300 researchers and staff come to work at Intellia. We are motivated by our mission to develop curative genome editing treatments for people living with severe diseases.

Many of us pursuing work in the biotechnology industry are inspired by the loss of a loved one or someone in our community who is living with a disease.
Read a message from Intellia President and CEO John Leonard, M.D.

Our History

Click on the videos in this interactive timeline to hear from employees and members of the Intellia community about our journey. Join in on the conversation using #RoadtotheClinic on social media.

2014
Starting up
Rodolphe Barrangou
Watch
2015
First lab space
Marie Keenan
Watch
2016
IPO
Jess Seitzer
Watch
2018
First in vivo editing in non-human primates
Cindy Shaw
Watch
2018
Intellia's first publication
Reynald Lescarbeau
Watch
2019
IND-enabling studies
Jonathan Phillips
Watch
2021
First clinical data of in vivo editing in humans
David Lebwohl
Watch

Check back here for more video updates from us!

Menu